Maaike Labots
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Maaike Labots has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Adriaan A. Lammertsma
University Medical Center Groningen, University of Groningen
1 shared publication - Albert D. Windhorst
Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan, 1117, Amsterdam, The Netherlands
1 shared publication - Elizabeth Cunera Maria de Lange
Division of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research Leiden University Leiden The Netherlands
1 shared publication - Jonas Eriksson
Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden
1 shared publication - Joost Verbeek
Department of Nuclear Medicine & PET Research, VU University Medical Center, Amsterdam, The Netherlands
1 shared publication - Marissa Rongen
Department of Nuclear Medicine & PET Research, Radionuclide Centre, VU University Medical Center, P.O. box 7057, Amsterdam 1081, HV, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 1 January 2012
- Published by Springer Nature in EJNMMI Research
- Vol. 2 (1) , 36
[11C]phenytoin revisited: synthesis by [11C]CO carbonylation and first evaluation as a P-gp tracer in rats
At present, several positron emission tomography (PET) tracers are in use for imaging P-glycoprotein (P-gp) function in man. At baseline, substrate tracers such as R-[11C]verapamil display low brain concentrations with a distribution volume of around 1. [11C]phenytoin is supposed to be a weaker P-gp substrate, which may lead to higher brain concentrations at baseline. This could facilitate assessment of P-gp function when P-gp is upregulated. The purpose of this study was to synthesize [11C]phenytoin and to characterize its properties as a P-gp tracer.
- 1 January 2012
- Published by Springer Nature in EJNMMI Research
- Vol. 2 (1) , 36
Open Access[11C]phenytoin revisited: synthesis by [11C]CO carbonylation and first evaluation as a P-gp tracer in rats
At present, several positron emission tomography (PET) tracers are in use for imaging P-glycoprotein (P-gp) function in man. At baseline, substrate tracers such as R-[11C]verapamil display low brain concentrations with a distribution volume of around 1. [11C]phenytoin is supposed to be a weaker P-gp substrate, which may lead to higher brain concentrations at baseline. This could facilitate assessment of P-gp function when P-gp is upregulated. The purpose of this study was to synthesize [11C]phenytoin and to characterize its properties as a P-gp tracer.